Imatinib Mesylate and Interferon Alfa in Treating Patients With Chronic Myelogenous Leukemia
Clinical trial NCT00015847 · TERMINATED
Trial details
- NCT number
- NCT00015847
- Sponsor
- OHSU Knight Cancer Institute
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2001-04-01
- Primary completion
- 2011-05-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.